Alectinib-a new chapter in the management of ALK-positive lung cancer

被引：4
作者：
Gainor, Justin F. [1 ]
机构：
[1] Massachusetts Gen Hosp, Dept Med, 55 Fruit St, Boston, MA 02114 USA
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2016年 / 5卷 / 03期
关键词：
CRIZOTINIB; INHIBITOR; RESISTANCE; CHEMOTHERAPY; CERITINIB; SAFETY;
D O I：
10.21037/tlcr.2016.03.05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：343 / 346
页数：4
相关论文
共 24 条
[1]  
[Anonymous], ANN ONCOL
[2]   Crizotinib for EML4-ALK positive lung adenocarcinoma: a hope for the advanced disease? [J].
Antoniu, Sabina Antonela .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (03) :351-353
[3]  
Awad Mark M, 2014, Clin Adv Hematol Oncol, V12, P429
[4]   Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study [J].
Camidge, D. Ross ;
Bang, Yung-Jue ;
Kwak, Eunice L. ;
Iafrate, A. John ;
Varella-Garcia, Marileila ;
Fox, Stephen B. ;
Riely, Gregory J. ;
Solomon, Benjamin ;
Ou, Sai-Hong I. ;
Kim, Dong-Wan ;
Salgia, Ravi ;
Fidias, Panagiotis ;
Engelman, Jeffrey A. ;
Gandhi, Leena ;
Jaenne, Pasi A. ;
Costa, Daniel B. ;
Shapiro, Geoffrey I. ;
LoRusso, Patricia ;
Ruffner, Katherine ;
Stephenson, Patricia ;
Tang, Yiyun ;
Wilner, Keith ;
Clark, Jeffrey W. ;
Shaw, Alice T. .
LANCET ONCOLOGY, 2012, 13 (10) :1011-1019
[5]   Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial [J].
Chang, Eric L. ;
Wefel, Jeffrey S. ;
Hess, Kenneth R. ;
Allen, Pamela K. ;
Lang, Frederick F. ;
Kornguth, David G. ;
Arbuckle, Rebecca B. ;
Swint, J. Michael ;
Shiu, Almon S. ;
Maor, Moshe H. ;
Meyers, Christina A. .
LANCET ONCOLOGY, 2009, 10 (11) :1037-1044
[6]   Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases [J].
Costa, Daniel B. ;
Shaw, Alice T. ;
Ou, Sai-Hong I. ;
Solomon, Benjamin J. ;
Riely, Gregory J. ;
Ahn, Myung-Ju ;
Zhou, Caicun ;
Shreeve, S. Martin ;
Selaru, Paulina ;
Polli, Anna ;
Schnell, Patrick ;
Wilner, Keith D. ;
Wiltshire, Robin ;
Camidge, D. Ross ;
Crino, Lucio .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (17) :1881-1888
[7]   CSF Concentration of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib [J].
Costa, Daniel B. ;
Kobayashi, Susumu ;
Pandya, Shuchi S. ;
Yeo, Wee-Lee ;
Shen, Zhongzhou ;
Tan, Weiwei ;
Wilner, Keith D. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :E443-E445
[8]   The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non-Small Cell Lung Cancer [J].
Friboulet, Luc ;
Li, Nanxin ;
Katayama, Ryohei ;
Lee, Christian C. ;
Gainor, Justin F. ;
Crystal, Adam S. ;
Michellys, Pierre-Yves ;
Awad, Mark M. ;
Yanagitani, Noriko ;
Kim, Sungjoon ;
Pferdekamper, AnneMarie C. ;
Li, Jie ;
Kasibhatla, Shailaja ;
Sun, Frank ;
Sun, Xiuying ;
Hua, Su ;
McNamara, Peter ;
Mahmood, Sidra ;
Lockerman, Elizabeth L. ;
Fujita, Naoya ;
Nishio, Makoto ;
Harris, Jennifer L. ;
Shaw, Alice T. ;
Engelman, Jeffrey A. .
CANCER DISCOVERY, 2014, 4 (06) :662-673
[9]   Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study [J].
Gadgeel, Shirish M. ;
Gandhi, Leena ;
Riely, Gregory J. ;
Chiappori, Alberto A. ;
West, Howard L. ;
Azada, Michele C. ;
Morcos, Peter N. ;
Lee, Ruey-Min ;
Garcia, Linta ;
Yu, Li ;
Boisserie, Frederic ;
Di Laurenzio, Laura ;
Golding, Sophie ;
Sato, Jotaro ;
Yokoyama, Shumpei ;
Tanaka, Tomohiro ;
Ou, Sai-Hong Ignatius .
LANCET ONCOLOGY, 2014, 15 (10) :1119-1128
[10]   Alectinib Salvages CNS Relapses in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib [J].
Gainor, Justin F. ;
Sherman, Carol A. ;
Willoughby, Kathryn ;
Logan, Jennifer ;
Kennedy, Elizabeth ;
Brastianos, Priscilla K. ;
Chi, Andrew S. ;
Shaw, Alice T. .
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (02) :232-236
123